Faricimab by Roche is a strong competitor to Eylea.
age-related macular degeneration (AMD)
Posted inNew Drugs, Regulatory
Susvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration
Roche offered a convenient replacement for the traditional Lucentis.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Empaveli: Powerful New Drug for Paroxysmal Nocturnal Hemoglobinuria
Pegcetacoplan is more effective in treating paroxysmal nocturnal hemoglobinuria compared to Soliris.